In the study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and published in Science Immunology, the researchers found that CD4+ T cells, traditionally called ‘helper T cells’ for their role in aiding the activation of other immune cells, are remarkably effective in controlling melanoma.
How the pharma industry can benefit from using modular real-time technology – Pharmaceutical Technology
The more intricate pharmaceutical products become, the more stable supply chains will need to be. New technologies are entering the market that could help. With